MGX

Neutral

Genome-editing firm Metagenomi CEO joins Jefferies June 4 fireside chat

Metagenomi Therapeutics (Nasdaq: MGX) announced that its President and CEO, Jian Irish, will participate in a fireside chat at the Jefferies Global He...

Stock Titan 4 days ago 0

Neutral

Metagenomi Highlights Q1 Progress on MGX-001 Gene Therapy

Metagenomi reported strong Q1 2026 financial results, with cash reserves of $140.2 million expected to fund operations through Q4 2027. The company ad...

TipRanks 2 weeks ago 0